ReCET Study | Type 2 Diabetes | Clinical Trial
What is the ReCET Procedure? The ReCET Procedure is a non-surgical, investigational treatment designed to improve blood sugar control in adults with Type 2 Diabetes.
ReCET Treatment by Endogenex
ReCET uses principles of metabolic change through Intestinal Cellular Regeneration to induce regrowth of healthy signaling cells in the duodenum to slow progression of T2D.
Researchers study novel endoscopic therapy for type 2 diabetes
Feb 24, 2024 · Endoscopic re-cellularization via electroporation therapy (ReCET), also known as endoscopic duodenal mucosal regeneration, is a novel endoscopic procedure and device …
Diabetes Breakthrough: New Treatment Eliminates Insulin
Oct 17, 2024 · This innovative approach, which combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with semaglutide, resulted in the elimination of …
Endoscopic Intestinal Re-Cellularization Therapy in Type II …
The ReCET device is designed to treat the lining of the first part of the small intestine (duodenum) in order to improve blood sugar control in individuals with T2D. The procedure is done through …
Endogenex designed the ReCET system to treat type 2 diabetes
Jun 20, 2025 · ReCET treats inflamed and dysfunctional tissue associated with type 2 diabetic duodenopathy, delivering nonthermal pulsed electric field (PEF) energy to mucosal and …
Recellularization via electroporation therapy of the duodenum …
Recellularization via electroporation therapy (ReCET) is a novel endoscopic procedure that uses electroporation to induce cellular apoptosis and subsequent reepithelization.
852-P: Duodenal Recellularization via Electroporation Therapy (ReCET …
Jun 20, 2023 · In this study we aimed to eliminate insulin in T2D patients using a single ReCET procedure combined with GLP-1RA. Safety, feasibility, and efficacy of ReCET using the …
ReCET procedure plus semaglutide may eliminate insulin …
Oct 14, 2024 · A promising new treatment strategy for type 2 diabetes (T2D) that combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with …
Endogenex™ Announces First Patient Enrolled in the ReCET …
Oct 15, 2024 · The ReCET Study is a pivotal trial approved by the U.S. Food and Drug Administration (FDA) under the Investigational Device Exemption (IDE). The study aims to …